Saturday, 17 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

12:29 IST NSE
Fund RaiseRavindra Energy Ltd RELTD

Ravindra Energy Fund Raise of ₹205 Cr

Ravindra Energy approved a Rs 205 Crore rights issue at Rs 101 per share. The 1:9 entitlement ratio aims to strengthen the company's capital position.

Value
₹205.0 Cr
12:33 IST NSE
Merger & RestructuringVedanta Ltd VEDL

Vedanta Merger & Restructuring

Vedanta Limited announced the cost of acquisition apportionment for its demerger into four resulting companies. This guidance helps shareholders determine post-demerger tax costs for their holdings.

12:42 IST NSE
Credit RatingIDFC First Bank Ltd IDFCFIRSTB

IDFC First Bank Credit Rating

ICRA reaffirmed IDFC First Bank's debt instrument ratings at [ICRA]AA+/Stable for ₹12,520 Crore. Ratings for matured NCDs totaling ₹3,883.70 Crore were withdrawn following full redemption.

Value
₹12,520 Cr
12:48 IST NSE
Debt & BorrowingNTPC Ltd NTPC

NTPC Debt & Borrowing: ₹5.4 Cr

NTPC Limited successfully completed the ₹5.40 Crore redemption and interest payment for its SRS 45 STRPP I bonds. The full redemption occurred on May 16, 2026.

Value
₹5.40 Cr
12:50 IST NSE
Debt & BorrowingNTPC Ltd NTPC

NTPC Debt & Borrowing

NTPC Limited has redeemed its Series 45 STRPP I bonds upon maturity on May 16, 2026. The company is now delisting these securities from the NSE.

14:42 IST NSE
Debt & BorrowingIDBI Bank Ltd IDBI

IDBI Bank Debt & Borrowing: ₹10,000 Cr

IDBI Bank approved issuing ₹10,000 Crore in long-term rupee bonds for infrastructure and housing finance. The issuance will occur in tranches through March 2027.

Value
₹10,000 Cr
Execution
up to March 31, 2027
09:50 IST NSE
Regulatory ApprovalAurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Regulatory Approval

Aurobindo Pharma subsidiary CuraTeQ received CDSCO marketing approval for Bevqolva, a bevacizumab biosimilar. The authorisation permits domestic manufacturing and marketing for metastatic colorectal cancer treatment.

12:51 IST NSE
Results CorrectionSJVN Ltd SJVN

SJVN Results Correction

SJVN Limited corrected typographical errors in its March 2026 financial results where 'Unaudited' appeared instead of 'Audited'. All financial figures remain unchanged from earlier submissions.

16:44 IST BSE
Capacity ExpansionRishiroop Ltd RISHIROOP

Rishiroop Capacity Expansion: ₹0.25 Cr Investment

Rishiroop Ltd renewed its office lease with promoter entity Rishiroop Polymers for 11 months. Monthly rent is ₹0.25 lakh, ensuring continued operational capacity.

Value
₹0.25 Cr
Execution
11 months
16:19 IST BSE
Employee Stock OptionsFusion Finance Ltd FUSION

Fusion Finance Employee Stock Options

Fusion Finance granted 1,50,000 stock options at Rs. 203.95 each under its ESOP 2023 plan. The grant aims to incentivize employees with a ₹3.06 Crore total value.

Value
₹3.06 Cr
Execution
8 years from the date of vesting
11:49 IST NSE
Fund RaiseCraftsman Automation Ltd CRAFTSMAN

Craftsman Automation Fund Raise of ₹2,000 Cr

Craftsman Automation approved raising up to ₹2000 Crore through equity or other securities. Proceeds will primarily fund repayment or prepayment of outstanding borrowings.

Value
₹2,000 Cr
16:39 IST BSE
Promoter SellingKPT Industries Ltd KULKPOWT

KPT Industries Promoter Selling: ₹5.14 Cr

Promoters Mrs. Nirmala and Mr. Dilip Kulkarni sold shares worth ₹5.14 Crore through open market transactions. This disposal reduces their aggregate holding in the company.

Value
₹5.14 Cr